GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Peter Lynch Fair Value

M1 Kliniken AG (XTER:M12) Peter Lynch Fair Value : €2.76 (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, M1 Kliniken AG's PEG is 1. M1 Kliniken AG's 5-Year TTM EBITDA Growth Rate is 14.08. M1 Kliniken AG's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was €0.20. Therefore, the Peter Lynch Fair Value for today is €2.76.

As of today (2024-05-11), M1 Kliniken AG's share price is €16.00. M1 Kliniken AG's Peter Lynch fair value is €2.76. Therefore, M1 Kliniken AG's Price to Peter Lynch Fair Value Ratio for today is 5.80.


The historical rank and industry rank for M1 Kliniken AG's Peter Lynch Fair Value or its related term are showing as below:

XTER:M12' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.89   Med: 2   Max: 6.12
Current: 5.8


During the past 9 years, the highest Price to Peter Lynch Fair Value Ratio of M1 Kliniken AG was 6.12. The lowest was 0.89. And the median was 2.00.


XTER:M12's Price-to-Peter-Lynch-Fair-Value is ranked worse than
92.35% of 183 companies
in the Healthcare Providers & Services industry
Industry Median: 1.34 vs XTER:M12: 5.80

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


M1 Kliniken AG Peter Lynch Fair Value Historical Data

The historical data trend for M1 Kliniken AG's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG Peter Lynch Fair Value Chart

M1 Kliniken AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only - 7.12 4.64 8.40 2.76

M1 Kliniken AG Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.40 - 2.76 -

Competitive Comparison of M1 Kliniken AG's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, M1 Kliniken AG's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M1 Kliniken AG's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's Price-to-Peter-Lynch-Fair-Value falls into.



M1 Kliniken AG Peter Lynch Fair Value Calculation

M1 Kliniken AG's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 14.08 *0.196
=2.76

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was €0.20.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


M1 Kliniken AG  (XTER:M12) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 14.08 instead of 15 in this case.

M1 Kliniken AG's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=16.00/2.76
=5.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


M1 Kliniken AG Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


M1 Kliniken AG (XTER:M12) Business Description

Traded in Other Exchanges
Address
Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Executives
Kilian Brenske Board of Directors
Attila Strauss Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines